Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Like many doctors, I often encountered patients suffering from musculoskeletal pain who had tried a variety of allopathic and natural treatment modalities with limited or no success. In many cases, I ...

This potentially useful study reports a new method for restoring sperm motility. Strengths are in the methodology being developed, but the conclusions require additional experimental support. The ...

Introduction: Furosemide (FUR) remains the cornerstone agent to decongest patients with heart failure. Given the challenges associated with intravenous (IV) administration, an 80mg/10mL buffered ...

The blood vessels are shown in green and the amyloid-beta plaque in red. Images courtesy of the researchers. For decades, Alzheimer’s disease has been like an unbreakable fortress. Scientists have ...

Injecting a fatty acid that is used to make very long fat molecules into the eyes of elderly mice improved their vision for up to a month, indicating that the natural compound could potentially be ...

The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, making it the first and only subcutaneously (SC)-administered immune ...

The Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Leqembi ® Iqlik ™, a once weekly lecanemab-irmb subcutaneous (SC) injection, for maintenance dosing to ...